|
|
Department of PsychiatryDivision of Substance Dependence
Recent Publications/PresentationsGelhorn HL, Sakai JT, Price RK, Crowley TJ. (in press). DSM-IV Conduct disorder criteria as predictors of antisocial personality disorder. Comprehensive Psychiatry. Hartman CA, Gelhorn H, Crowley TJ, Sakai J, Stallings MC, Young SE, Corley R, Hewitt JK, Hopfer CJ. (in press). An Item Response Theory analysis of DSM-IV marijuana abuse and dependence criteria in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, Zerbe G, Freedman R. (in press). Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology. Anderson KG, Tapert SF, Moadab I, Crowley TJ, Brown SA. (2007). Personality risk profile for conduct disorder and substance use disorders in youth. Addictive Behaviors, 32: 2377-2382. Banich MT, Crowley TJ, Thompson LL, Jacobson BJ, Liu X, Raymond KM, Claus ED. (2007). Brain activation during the Stroop task in adolescents with severe substance and conduct problems: A pilot study. Drug and Alcohol Dependence, 90, 175-182. Crowley TJ. (2007). Adolescents and substance related disorders: Research agenda to guide decisions in DSM-V, in Diagnostic Issues in Substance Use Disorders: Refining the Research Agenda for DSM-V. eds. Saunders, J.B., Schuckit M.A., Sirovatka, P.J., Regier, D.A. pages 203-220. Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Schlaepfer I, Smolen A, Stallings MC, Young SE, Zeiger JS. (2007). Association of the neuronal nicotinic receptor b2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics – Neuropsychiatric Genetics, 144B, 596-604. Hopfer CJ, Lessem JM, Hartman CA, Stallings MC, Cherny SS, Corley RP, Hewitt JK, Krauter KS, Mikulich-Gilbertson SK, Rhee SH, Smolen A, Young SE, Crowley TJ. (2007). A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: Evidence for linkage on chromosomes 3 and 9. Drug and Alcohol Dependence, 89: 34-41. Schlaepfer I, Clegg HV, Corley RP, Crowley T, Hewitt JK, Hopfer CJ, Krauter K, Lessem J, Rhee SH, Stallings MC, Wehner JM, Young SE, Ehringer MA. (2007). The human protein kinase C-gamma gene (PRKCG) as a susceptibility locus for hyperactive/impulsive behaviors. Addiction Biology, 12, 200-209. Sakai JT, Hopfer CJ, Hartman C, Haberstick BC, Smolen A, Corley RP, Stallings MC, Young SE, Timberlake D, Hewitt JK, Crowley TJ. (2007). Test of association between TaqIA A1 allele and alcohol use disorder phenotypes in a sample of adolescent patients with serious substance and behavioral problems. Drug and Alcohol Dependence, 88, 130-137. Crowley TJ, Raymond KM, Mikulich-Gilbertson SK, Thompson LL, Lejuez CW. (2006). A risk-taking “set” in a novel task among adolescents with serious conduct and substance problems. Journal of the American Academy of Child and Adolescent Psychiatry, 45: 175-183. Current & Ongoing Research SupportTitle: Antisocial Drug Dependence: Genetics Title: A Family Study of Substance Use and Conduct Disorder. Title: Substance Dependent Adolescents: Imaging Risk-Taking Title: NIAAA Institutional Postdoctoral Training Grant: Behavioral Pharmacogenetics of Drug and Alcohol Abuse Completed Research SupportTitle: Genetics of Adolescent Antisocial Drug Dependence
Title: Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents with Substance Use Disorders (SUD) - Pharmacogenetics of Treatment Response
This study seeks to collect DNA from participants in a double-blind, placebo-controlled, multisite trial of OROS-MPH for adolescents with attention-deficit/hyperactivity disorder and at least one substance use disorder. Genotypes in the dopamine system will be determined and their possible association with treatment response will be tested. Title: Method to Extend Research in Time Award
Substance-Use & Conduct Disorder: Motility, Neuropsych Rocky Mountain Regional Clinical Trials Node
Conduct studies of behavioral, pharmacological, and integrated behavioral and pharmacological treatment inventions of therapeutic effect in rigorous, multi-site clinical trials to determine effectiveness across a broad range of community-based treatment settings and diversified patient populations. Educational ActivitiesMedical Students Lecturer, The Multiple Etiologies of Substance Dependence. 2 hrs in second-year Medical Student Neuroblock course. Course Director, Research in Drug and Alcohol Abuse (Psych 8610). Students in this elective research course participate in the ongoing research projects of the Division of Substance Dependence. Mentor, Psychiatry Scholars Program, Division Faculty serve as mentors to medical students wishing to fulfill their independent learning requirement. Psychiatric Residents Mentoring of Junior Faculty & Post-Doctoral Fellows Dr. Crowley is an “outside” mentor in the special NIDA K-award program of the American Academy of Child and Adolescent Psychiatry. This program is directed by Dr. Paula Riggs. Dr. Crowley mentors Dr. Heather Gelhorn, a post-doctoral fellow in the Division of Substance Dependence. Opportunities for Research Participation of Medical Students and Residents Residents: Numerous residents in adult and child psychiatry have conducted research leading to published papers during electives with Dr. Crowley. They have worked on projects currently ongoing in the Division. |
|
||||||||||||||||||||||||||||||